Qi Li

2PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 28, 2026
A glycan superbinder reveals polysialylated-CD56 as a precision biomarker for pancreatic cancer.

|Dec 01, 2025
Tislelizumab and Hypofractionated Radiotherapy plus Nab-Paclitaxel/Gemcitabine as Conversion Therapy for BRPC/LAPC: A Phase II Trial with Dynamic Biomarker Monitoring.

Jiayao Ni, Yi Sun, Hao Cheng

Pageof 1